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During insect development, steroid hormones interact with two members of the 
nuclear receptor superfamily, ecdysone receptor (EcR) and Ultraspiracle (USP) to bring 
about cellular changes.  To determine the functional properties of mutations of serine and 
threonine residues that are possible targets of phosphorylation by protein kinase C (PKC) 
in the gene that encodes the D. melanogaster USP, we developed a heterologous 
mammalian cell culture system.  When tested with the three natural isoforms of D. 
melanogaster EcR, one of the five mutations, S112A in the DNA-binding domain of 
USP, reduced basal and induced transcriptional activity, by itself and in most 
combinations with other mutations.  Treatment with a PKC inhibitor, chelerythrine 
chloride (CC), itself had no effect on the transcriptional activity with wild-type USP and 
with any of the combination of mutations suggesting that the difference in activity caused 
by S112A does not involve phosphorylation.  These mutational studies create a 
foundation for future in vivo experiments. 
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CHAPTER I 
INTRODUCTION 
Background Information 
 Steroid hormone levels fluctuate during developmental, reproductive and 
metabolic events.  Hormone titer peaks trigger and regulate cellular changes associated 
with these events.  During development in Drosophila melanogaster and other insects, 
peaks of the insect steroid hormones, the ecdysteroids, trigger cellular events that lead to 
developmental changes such as larval molting, puparium formation, imaginal disc and 
eye differentiation, and metamorphic development (Henrich 2005; Laudet and Bonneton 
2005).   
Steroid induced developmental processes begin when the steroids enter the cell by 
passing through the membrane and then bind to a nuclear receptor. Once a ligand binds to 
its cognate receptor, a functional complex is formed with either an identical receptor 
(homodimer) or another receptor (heterodimer).  The dimer then binds to a specific 
sequence in the promoter region of a target gene that is known as the hormone response 
element (HRE; Evans 1988).  When bound to the HRE, the dimerized nuclear receptor 
recruits comodulators to create a complex that includes RNA polymerase to transcribe the 
target genes.  Then the mRNA encoded by the target genes is synthesized into new 
proteins for cell processes such as differentiation. 
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DNA binding and transcriptional regulation of target genes are key functions of 
nuclear receptors (Yao et al., 1993; Lezzi et al., 2002; Grebe,et al., 2003; Henrich 2005), 
defined by the distinct functional domains characteristic of the protein class.  The N-
terminal or A/B domain interacts with other transcription factors (Robinson-Rechavi et 
al., 2003).The highly conserved C domain or DNA binding domain (DBD) contains two 
cysteine-cysteine zinc fingers which interact with the HRE in the promoter of hormone-
responsive genes.  In fact, these zinc finger sequences typically define most members of 
the nuclear receptor superfamily, such as thyroid receptor (TR), glucocorticoid receptor 
(GR), retinoic acid receptor (RAR), farnesoid X receptor (FXR), and retinoid X receptor 
(RXR).  The insect homologs of FXR and RXR are the ecdysone receptor (EcR) and 
Ultraspiracle receptor (USP) respectively (Oro et al., 1990; Henrich et al., 1990; Forman 
et al., 1995).  The D domain, or the hinge region, is important for nuclear localization and 
DNA recognition.  This region has been implicated in ligand dependent 
heterodimerization along with the moderately conserved E or ligand binding domain 
(LBD; Robinson-Rechavi et al., 2003; Przibilla et al., 2004). The LBD is involved in the 
recognition of the specific ligand, dimerization between the receptor and other proteins 
including other nuclear receptors, regulation of hormone dependent transcriptional 
activity and interaction with protein comodulators.  Generally, nuclear receptors are able 
to stimulate gene transcription without ligand, but induce higher transcriptional levels in 
the presence of the cognate ligand that the LBD recognizes (Yao et al., 1993).  When the 
ligand binds to the nuclear receptor protein, a conformational change occurs that enables 
the protein to bind with a higher affinity to the promoter of the target gene.   
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Ecdysteroids were originally known as the molting hormones.  During mid-
embryogenesis in D. melanogaster EcR/USP dimerization presumably occurs in response 
to an ecdysteroid peak (Zitnan and Adams 2005).  The activated complex triggers 
processes in larval development that cause D. melanogaster to molt.  The pulses of the 
hormone 20-hydroxyecdysone (20E) coordinate the transition of the developmental 
stages, including the molts to the second and third larval instars and the transition 
between larval, prepupal, pupal and adult stages (Li and Bender 2000).   
Ecdysteroids are released into the hemolymph and are transported to target cells, 
such as salivary glands.  The ecdysteroid then passes through the membrane to enter the 
cell, binds to its receptor, and finally, regulates transcription.  In the salivary gland, a puff 
occurs on a region of the chromosome that appears as swelling of a chromosomal band as 
a result of the increasing level of transcription of a gene that is induced by the 20E 
(Ashburner et al., 1974).   
The puffing of individual genes occurs over time.  Some puffs occur within 
minutes after application of 20E, other puffs appear after several hours, and as the first 
puffs regress the next sequence of puffs start to increase in size.  The early puffs respond 
to a peak of 20E and induce the expression of a set of regulatory genes.  Then, with the 
induction of these regulatory genes as the ecdysteroid peak subsides, the late genes are 
induced by the early puff gene products, and the late puffs encode proteins that regulate 
subsequent biological responses (Thummel 2002), as early puffs regress.  Therefore the 
initiation of the puffs is dependent on the presence of ecdysteroids, but once triggered, 
changes continue to occur that are not dependent on ecdysteroids. 
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EcR and USP function as a heterodimer.  EcR and USP alone are unable to 
achieve high affinity binding or transcriptional activation, and their activity is dependent 
on dimerization (Yao et al., 1993).  Once this heterodimer is formed, the complex is able 
to interact with a palindromic sequence in heat shock protein 27 ecdysone response 
element (hsp27-EcRE) (Riddihough and Pelham 1986). 
Ecdysteroids bind to EcR to regulate puff gene expression, but less is known 
about EcR’s heterodimeric partner, Ultraspiracle (USP).  Studies have demonstrated that 
20E binds with EcR, and there is only indirect evidence that juvenile hormone is the 
ligand that interacts with USP.  Some studies have shown that USP physically interacts 
with juvenile hormone (JHIII), also known as sesquiterpenoid methyl epoxyfarnesoate, 
and that an USP homodimer can be induced by JHIII with a specific promoter element 
(Xu et al., 2002). 
The usp gene maps to 2C1-3 on the distal portion of the X chromosome and has a 
2.7kb transcript with no introns (Henrich et al., 1990; Oro et al., 1990; Shea et al., 1990; 
Henrich et al., 1994; Hall and Thummel 1998).  The USP protein is homologous to 
vertebrate retinoid X receptor (RXR) with the LBD (49% identity between RXR and 
USP) and DBD (86%) showing several regions of amino acid identity.  The proteins 
would be even more similar in sequence except for two glycine-rich spacers that only 
appear in the USP LBD and are not found in RXRs (Henrich et al., 1990; Oro et al., 
1990; Yao et al., 1992).  Like mammalian RXR, USP can heterodimerize with the 
mammalian nuclear receptor retinoid acid receptor (RAR) (Yao et al., 1992).  USP in 
vitro achieves high affinity DNA binding to response elements as a dimer with thyroid 
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receptor (TR), peroxisome proliferator activated receptor (PPAR), and vitamin D receptor 
(VDR) (Yao et al., 1992, Song et al., 2003). 
The USP protein is present throughout embryogenesis, and is required in 
ecdysone-dependent processes, such as larval molting, growth and pupation (Oro et al., 
1992; Hall and Thummel 1998).  The loss of function usp result in death at the end of the 
first larval instar (Oro et al., 1990; Henrich et al., 1994).  These mutations include three 
missense substitutions, usp3, usp4, usp5 and a nonsense mutation, usp2, within the DBD.  
The missense substitution usp3 is amino acid R160H and is found in the 5’ section of the 
second zinc finger, usp4 is the amino acid R130C which is found in the linker between 
the two fingers, usp5 is the amino acid R153K in the second zinc finger and the usp2 
mutation truncates the DBD (Oro et al, 1990; Henrich et al., 1994; Lee et al., 2000). Also, 
the absence of USP in the late third instar prevents a response to 20E and leads to a 
developmental arrest before metamorphosis (Hall and Thummel 1998).   
The usp mutations produce different phenotypes at various developmental stages.  
Also, usp appears to be required both maternally and postzygotically (Perrimon et al., 
1985; Oro et al., 1992; Henrich et al., 1994).  The offspring that lack normal maternal usp 
function die as embryos and have cuticular scarring in the posterior abdominal segments 
(Perrimon et al., 1985).  Lethal mutation of usp postzygotically prevents molting at the 
end the first larval instar and mutants lacking normal usp die during the molt from the 
first to second instar.  Extra posterior spiracles form during the incomplete molt, thus the 
mutation’s name, ultraspiracle (Perrimon et al., 1985).  When a fly obtains an increased 
dose of mutant usp alleles along with a single wild-type allele, the progeny show an 
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increased frequency of cleft thorax (Henrich et al. 1994).   Therefore, usp appears to be 
required both maternally and postzygotically (Perrimon et al., 1985; Oro et al., 1992; 
Henrich et al., 1994).   
USP is necessary during adult eye movement for regulating the progression of 
morphogenetic furrow movement.  The morphogenetic furrow is a monolayer between 
undifferentiated cells and the cells that form the ommatidia, or eye units. (Oro et al., 
1992; Zelhof et al., 1997).  The loss-of-function usp mutations have the same phenotypes 
as some EcR mutations, in that they both arrest at the first larval molt and are unable to 
shed the cuticle. In addition to being unable to shed the cuticle, EcR mutants are unable 
to shed their mouth hooks between the first and second instars and the second and third 
instar (Schubiger et al., 1998).   
In order to test the effect mutations within EcR and USP and without using D. 
melanogaster, in vitro experiments have been utilized.  Heterologous mammalian cell 
cultures have been used for many experiments to examine the transcriptional activity of 
the EcR/USP heterodimer.  The mammalian cells have no endogenous response to 
ecdysteroids, and therefore will become responsive to ecdysteroids only when 
cotransfected with EcR and USP, unlike insect cell lines that are naturally responsive to 
ecdysteroids (Christopherson et al., 1992; Yao et al., 1992; Palli et al., 2003; Beatty et al., 
2006).  Consequently, in using the mammalian cells transfected with EcR/USP and 
treated with hormone, the assays produce information about receptor function, and the 
effect of alterations to the receptor that cause a down-regulation or an up-regulation in the 
transcriptional activity produced by the receptor.  The effects of altered receptors have 
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been examined using this approach, and this is useful for testing the transcriptional 
activity of the receptor in its wild-type form and in structurally altered forms. 
Mammalian cell cultures cannot ultimately demonstrate how mutations will affect 
D. melanogaster.   Nevertheless, cell culture can serve as a gauge of the receptor’s 
capabilities, and can establish a basis for in vivo testing.  If a mutation has an effect on 
transcriptional activity in vitro, there is a chance the same effect will be seen in vivo.  
Mammalian cell culture does not include the effect the receptor has on different genes 
and tissues in D. melanogaster, but cell culture can test if the receptor and heterodimer is 
working proficiently to transcribe a gene carrying an EcRE in the promoter. If a mutation 
limits transcriptional activity in vitro, I hypothesize that the mutation will cause a 
phenotypic change in D. melanogaster and/or developmental arrest just as a natural EcR 
or usp mutation would because the receptor is not working at a normal level. 
Phosphorylation 
USP is a phosphoprotein and maybe regulated by phosphorylation (Song et al, 
2003).  When a molecule is phosphorylated, a phosphate group is added.  More 
importantly, phosphorylation is an essential mechanism for modification of the structure, 
activity, and lifetime of certain proteins and underlies the regulation of cellular 
metabolism through many agents including hormones, growth factors, tumor promoters 
and oncogenes (Weigel 1996; Song et al., 2003).   
The first evidence of phosphorylation was from an immunoblot over several 
developmental stages which showed two bands, though there is only a single usp gene 
(Henrich et al., 1994).  Song et al., (2003) also have investigated the effects of 
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phosphorylation during the developmental stages of D. melanogaster.  USP 
phosphorylation is associated with changes in 20E in D. melanogaster and it has been 
suggested that these hormonal level changes are responsible for eliciting USP 
phosphorylation in early wandering larvae.  In D. melanogaster, 60% of USP is in the 
phosphorylated form in the early wandering larval stage, a period that follows a small 
peak of ecdysteroids.  There is a decline of the phosphorylated form in the late wandering 
stage when 40-50% of USP remains phosphorylated.  Even in the absence of 20E, there 
have been reports of high levels of EcR and USP phosphorylation in Manduca sexta, but 
this has yet to be established in D. melanogaster (Song and Gilbert 1998).  This suggests 
that phosphorylation may also be regulated by another unknown signaling pathway, as 
has been reported in vertebrate systems (Song and Gilbert 1998; Song et al., 2003).  
Protein kinase C and casein kinase II have been suggested as activators of 20E induced 
USP phosphorylation. 
Four protein bands have been recognized from western blot analysis for 
Drosophila melanogaster USP.  These bands include molecular weights of 56kDa, 
54kDa, 48kDa and 46kDa, with the 48kDa and 46kDa bands only present in the midgut 
of the prepupae (Henrich et al., 1994; Song et al., 2003) and raise the possibility that USP 
exists in a phosphorylated form.  In order to test this further, Song et al., (2003) treated 
salivary glands of Drosophila melanogaster with λ-protein phosphatase.  The treatment 
led to a disappearance of the p56 band, and an increase of p54 indicating that p56 is the 
phosphorylated form of p54.  Song et al., (2003) also noted that phosphorylation of p54 is 
regulated by 20E. 
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Dephosphorylation did not affect EcR/USP complex formation in Manduca sexta, 
though phosphorylation may play an important role in regulating function of the complex 
(Song and Gilbert 1998).  To assess phosphorylation further, Song et al., (2003) 
identified via computer generating ten possible phosphorylation sites, seven protein 
kinase C (PKC) sites and three casein kinase II (CKII) sites.  A PKC inhibitor, 
chelerythrine chloride (CC), blocks USP phosphorylation in glands incubated with the 
inhibitor for one hour.  Also, CC reduces the expression of several 20E induced proteins 
presumably by inhibiting USP phosphorylation (Sun and Song 2006).  When the 20E 
induced early and late puff genes were incubated with 20E for six hours, the CC almost 
completely blocks the expression of these genes.  Accordingly, Sun and Song (2006) 
concluded that the PKC-mediated phosphorylation of USP is required for the expression 
of the 20E induced genes and proteins. These include the early puff genes E74A and 
E75B and the late puff genes DHR3, E78A, and E78B but not the early puff gene, E74B.   
Interestingly, E74B expression was expressed at a higher level in the presence of 
the PKC inhibitor.  The E74B gene is controlled by a low sensitivity promoter with 
induction occurring at 1 x 10-9 м and E74A is controlled by a high sensitivity promoter 
with induction occurring at 5 X 10-8 м (Karim and Thummel 1991).  Thus the 
phosphorylation state of USP could affect its relative affinity for the E74A and E74B 
promoters.   These results indicate that PKC mediated phosphorylation is responsible for 
USP phosphorylation and the inhibition of PKC activity reduces USP phosphorylation 
and 20E-induced gene transcription and translation.   
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Song et al., (2003) had not tested these computer generated PKC phosphorylation 
sites, so there is no evidence that they are true targets of PKC.  I hypothesize that these 
sites are indeed phosphorylation sites targeted by PKC. When USP is unable to be 
phosphorylated because of one or more PKC mutations, I hypothesize that the 
transcriptional levels of the EcR/USP complex will be reduced.  Also, because it is often 
necessary to destroy all the phosphorylation sites associated with a protein’s activity to 
see an effect, multiple mutated forms of USP will be made and tested for their activity.  I 
hypothesize that the transcriptional activity will be mostly, if not completely eliminated 
by the mutation of five PKC sites, including the three in the LBD and the two in the 
DBD.  Further, it is possible that some combinations of mutations for these computer-
generated PKC sites will have an effect on transcriptional activity.  An important starting 
point would be to investigate is whether the increase in EcR/USP activity normally 
caused by ecdysteroids is affected by mutations of the PKC phosphorylation sites in the 
heterologous cell culture system.  I hypothesize that a form of USP carrying all five 
possible mutated PKC phosphorylation sites will still have a dramatically reduced 
transcriptional level.  I will also test these mutant protein forms to determine if a 
phosphorylated form of USP exists and what its effect might be. 
Specific Aim of Project 
 This project aims: (1) to examine the effect of one and/or a combination of 
phosphorylation mutations within the USP DBD and LBD on the transcriptional activity 
of the EcR/USP heterodimer using Chinese Hamster Ovary (CHO) cells in a mammalian 
 10
 11
cell culture system and (2) to determine if there is a phosphorylated form of USP via 
western blotting procedures.
 
CHAPTER II 
MATERIALS AND METHODS 
This study utilizes in vitro (cell culture) techniques to gauge the effect of 
phosphorylation mutations in USP on the EcR/USP heterodimer’s function. The mutated 
pVP16-dUSPII DNA was transfected with the pcDNA3-dEcRA, pcDNA3-dEcRB1 or 
pcDNA3-dEcRB2 plasmids and a plasmid containing an ecdysteroid responsive reporter 
gene into Chinese hamster ovary (CHO) cells.  The reporter plasmid (pEcREtk-LUC) 
contains five tandem copies of the hsp27 EcRE attached to a constitutive thymidine 
kinase promoter and the luciferase reporter gene (pEcREtk-LUC). The pVP16-dUSPII 
vector is 4485 base pairs with a herpes simplex virus promoter and the USP coding 
region from amino acids 104-507 introduced into the EcoRI and HindIII restriction sites 
of pVP16 (Beatty et al., 2006).  The pcDNA3-dEcRA, pcDNA3-dEcRB1 and pcDNA3-
dEcRB2 vectors have a cytomegalovirus promoter and with the EcR coding region 
introduced between the BamHI and EcoRI or XbaI sites respectively (Mouillet, et al., 
2001).   
Once expressed in the CHO cells, the EcR/USP heterodimer interacts with the 
EcRE to induce the transcription of the luciferase (LUC) reporter gene.  Luciferase 
activity was measured from the extracted cellular proteins using a luminometer at an 
absorbance of 562nm, and was normalized by adjusting the activity with that of the β-
galactosidase (β-gal) gene expressing plasmid, from the extracted cellular proteins as 
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measured by its absorbance at 420nm.  Once the results from the initial reading of 
transcriptional activity in vitro were obtained, the levels of hormone were then altered in
cell culture experiments to see if increasing hormone has an effect on the transcriptional 
levels of these mutations. 
Site Directed Mutagenesis 
 Site directed mutations of five potential phosphorylation sites have been obtained 
individually and in all combinations.  First, the phosphorylation sites were selected for 
mutation based on the computer generated sites.  The amino acids selected were those 
PKC sites in the DBD and the LBD that were identified by Song et al., (2003).  Site-
directed mutations were created by changing one or two nucleotides in the codons so that 
four serine and one threonine amino acid residues were substituted with alanine (Figure 
1).  To create these mutations, complementary primers were designed to be centered over 
the codon of interest in order to replicate the DNA in both the 3’ and 5’ directions with 
the mutated codon in place of the original codon.  These primers were used to introduce 
the mutations into the pVP16-dUSPII vector (Beatty et al., 2006) by PCR amplification 
using the following primers and their reverse complements, with the altered codon 
underlined.  The substituted codons (alanine) are given below the codon that was 
modified: 
S112A:  5’ GGG GAT CGG GCC AGT GGC AAG CAC TAC G 3’  
           (GCT) 
T131A:  5’ GGC TTC TTT AAA CGC AGA GTG CGC AAG GAT CTC 3’ 
        (GCA) 
S393A:  5’ GC ATA TTG TCG GAG CTG AGT GTA AAG ATG AAG CCG CT 3’  
              (GCT) 
S468A:  5’ C GCT TTG CGA TCG ATC AGC CTG AAG TGC CAG GAT 3’  
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Figure 1: Placement of mutations in domains of USP (bold). The two serine residues in the N-terminal 
domain were not tested since this portion of USP was replaced with the VP16 activation domain for the cell 
culture experiments. 
S9 
N-
term 
S112A T131A S393A S468A S482A
DBD Hinge LBD 
S35 
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           (GCC) 
S482A:  5’ C TTC CGC ATT ACC AGC GAC CGG CCG CTG 3’   
            (GCC) 
These mutations were introduced individually and sequentially to produce the 
mutational combinations.  The PCR amplification was cycled according to the following 
protocol.  First, a five minute melting step at 94°C was used to obtain single stranded 
template DNA.  Then, temperature cycling was carried out for a total 30 cycles as 
follows:  94°C melting for one minute, 58°C annealing for one minute, and 68°C 
extension for two minutes per kilobase. 
 The PCR product with the appropriate mutations was then transformed into 45μl 
Ultracompetent XL10-Gold E. coli (Stratagene).  The cells were streaked onto Luria-
Bertani (LB) agarose plates with 50 μg/ml of ampicillin as a selective marker.  The 
transformed E. coli possesses ampicillin resistance and colonies were developed on the 
LB plate in 16-18 hours of allowed growth time at 37°C.  Single colonies were selected 
and picked using a 10μl pipette tip and then inoculated into 5ml LB liquid cultures with 
50 μg/ml of ampicillin and incubated at 37°C with shaking at 250rpm for eight hours. 
 A mini-prep kit (Qiagen) and protocol was then used to extract the plasmid DNA 
from the E. coli.  The plasmid concentrations were quantified spectrophotometrically 
(Eppendorf).  To verify that the correct DNA is indeed what was transformed, 500ng of 
DNA was digested for one hour at 37°C with EcoRI and/or HindIII restriction enzymes.  
Once the digestion was complete, the sample was electrophoresed on a 0.7% agarose gel 
with 1X ethidium bromide and a 1kb standard for size verification. 
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 The clones were then sequenced for verification to ensure that the appropriate 
mutation was present using commercial protocol (Amersham).  The obtained sequences 
were aligned with the dUSP reference sequence from NCBI to verify that the DNA 
contained the mutation(s) and no other unwanted mutations were present. 
Cell Culture 
 To test the transcriptional activity, experiments with CHO Cells were performed.  
The CHO cells were grown to confluence in 15ml Dulbecco’s Modified Eagle’s Medium-
complete (DMEM-C; DMEM/F-12, Gibco) growth medium with 5% fetal bovine serum 
(FBS, MP Biomedicals, Inc.) in a coated cell culture flask with 75cm2 of surface area.  
The flask of cells was then incubated in a 37°C water-jacket incubator with 5% CO2 
atmosphere.  When the cells reached confluence the growth medium was aspirated from 
the flask with a sterile Pasteur pipette in the sanitary environment of a laminar flow hood.  
Once aspirated, the cells were treated with 3ml of Trypsin (1X) causing the cells to 
separate from the flask bottom.  The trypsin was aspirated with a sterile Pasteur pipette 
after thirty seconds, with caution taken to avoid disturbing the cells.  After the trypsin 
was removed, the cells were resuspended in 10ml DMEM-C.  Fluctuation in pH can kill 
cells and therefore, it was important not to aerate the medium when resuspending the 
cells.  The resuspended cells were placed into a 50ml tube and a 10μl aliquot was 
removed and mixed with 90μl Trypan Blue in a 1.5ml tube.  The cell dilution created was 
counted in a hemocytometer and the cell density of the resuspended cells was calculated 
per milliliter. 
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 Six well plates were seeded with a density of 3.0x105 cells per well in 2ml of 
DMEM-C.  To aliquot the appropriate cell density evenly among each well, the cells and 
DMEM-C were combined together in a 50ml tube to a total volume of 12ml per plate.  
The cells were then placed back into the CO2 incubator to grow for 24 hours.  Once the 
cells reached approximately 75% confluence they were transfected with the experimental 
plasmids. 
 The cells were transfected with the reporter plasmids pEcREtk-LUC and pCHIII 
β-gal.  The β-gal is controlled by a constitutively active promoter resulting in the 
expression of β-gal, which then provides an indirect measure of the cell mass.  The 
plasmids encoding EcR isoforms and USP wild-type and mutants were cotransfected into 
the cells with the reporter plasmids.  After a four hour transfection period, a hormone 
treatment was applied to the transfected cells.  The cells were treated with one or more of 
the following reagents: the phytoecdysteroid, muristerone A (mur A; Alexis Corporation, 
San Diego, CA), juvenile hormone III (JHIII; Sigma, St. Louis), and the protein kinase 
inhibitor, CC (LC Laboratories, Woburn, MA).  Hormone treatments were as follows: 
0.1 μM mur A 
1.0μM mur A 
5.0μM mur A 
0.1μM mur A + 80μM JHIII 
80μM JHIII 
10μM CC 
10μM CC + 1.0μM mur A 
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A 1μM and 5μM mur A dose evokes maximum response from a wild-type 
receptor. A super maximal dosage (5μM) was used to verify that the mutations were not 
affecting the maximal response of the heterodimer by reducing the affinity of murA for 
the receptor.  Along with the hormone treatment, the PKC inhibitor, CC was added to the 
vehicle and 1μM MurA treatments to test the effects of the inhibitor in vitro.  After 24 
hours of the hormone treatment, the cells were harvested, their contents were extracted, 
and reporter gene assays were performed. 
 As described earlier, two assays were performed, a LUC assay and a β-gal assay.  
The LUC assay was performed to analyze the action of the EcR isoforms and the USP 
wild-type and mutants on the ecdysone responsive LUC reporter gene.  The β-gal assay 
was performed to measure the transfection efficiency in the experiment.  The LUC assay 
was normalized by the β-gal assay.  The β-gal was performed in duplicate to obtain 
results that are more reliable. 
Western Blot 
 The amount of cellular extract was determined from the β-gal activity and 100ng 
amount was loaded into each lane of an 8% polyacrylamide gel and was then 
electrophoresed (Invitrogen) at 150 V.  The polyacrylamide gel was then electroblotted 
(Minicell Blot Module, Invitrogen) on a PVDF membrane (0.2μm; Immun-Star, Bio Rad) 
at 350mA.  This membrane was soaked in blocking buffer (3% (w/v) milk powder, 
10mM Tris-HCl, 150mM NaCl, 1% (v/v) NaN3, 0.1% (v/v) Tween 20, pH 7.6).  Either 
the VP16 monoclonal mouse IgG antibody (Santa Cruz Biotechnology) or the anti-
phosphoserine polyclonal rabbit IgG (Chemicon International) was diluted 1:1000 in 
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blocking buffer.  The VP16 antibody probed the N-terminal domain of USPII wild type 
and mutant vectors to detect phosphorylation in the cell extracts.  The anti-phosphoserine 
antibody probed for phosphorylated serines with the cell extract.  Goat anti-mouse IgG or 
goat anti-rabbit IgG, peroxidase conjugated secondary antibodies (Santa Cruz 
Biotechnology), was diluted 1:2500 (10mM Tris-HCl, 150mM NaCl, 1% (v/v) NaN3, 
0.1% (v/v) Tween 20, pH 7.6) to detect specific immunosignals.  The membrane was 
exposed using chemiluminescence (BioRad), and the image was developed.
 
CHAPTER III 
RESULTS 
Background 
 Song et al., (2003) described five phosphorylation sites as potential targets of 
protein kinase C in the USP DBD and LBD.  Previous studies have shown that restriction 
of PKC phosphorylation via CC, a PKC inhibitor, leads to inhibition of USP 
phosphorylation and 20E-induced gene expression (Sun and Song 2006).  In vitro 
mammalian cell culture can be used to evaluate the effect of the PKC mutations on 
transcriptional activity in the absence and presence of hormone ligand, and the 
potentiation of transcription by JHIII.  In this study we have examined the effects of CC 
along with the effects of the mutated five PKC phosphorylation sites on USP in vitro.  
USP Mutations 
Site-directed mutations offer a strategy by which amino acid point mutations can be used 
to investigate the effects of specific amino acid substitutions in the CHO mammalian cell 
culture. The mutations studied here were five of the seven PKC induced phosphorylation 
sites previously identified by Song et al., (2003).  Two of the suggested PKC mutations 
are in the zinc fingers in the DBD (S112A and T131A), and three are in the LBD 
(S393A, S468A, and S482A). The other two PKC sites are in the N-terminal domain and 
have not been included because the natural USP N-terminal domain does not produce 
ecdysteroid activity in mammalian cell culture, and as a result has been replaced with the 
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VP16 activation domain (Beatty et al., 2006).  Mutations at all five sites were produced 
separately and in twelve different combinations ranging from two mutations to all five 
mutations combined in the VP16-USPII plasmid (Table 1). Each construct was verified 
by sequencing. 
 There are many mutations that disrupt the receptor by impairing receptor 
functions.  All of the mutations that have been chosen, with the exception of S112A, did 
not impair basal and ligand-dependent transcriptional activity.  That is, only S112A had a 
significant effect on the transcriptional activity in comparison to wild-type USP (Figure 
2).  The five single USP mutations and twelve combinations of mutations from Table 1 
were used to study the transcriptional activation with the three natural D. melanogaster 
EcR isoforms with USPII.   
Cell Culture 
Numerous mutations and mutational combinations displayed no effect on either basal or 
ligand-induced transcriptional activity when tested with any of the three EcR isoforms 
(Figure 2).  The individual mutants and combinations that exhibited no effect include the 
following single mutations: T131A, S393A, S468A, S482A; double mutation 
combinations: S112A/T131A, S393A/S468A, S393A/S482A, S468A/S482A; Triple 
mutation combination: S393A/S468A/S482A; and the quadruple mutational combination: 
T131A/S393A/S468A/S482A.  By contrast, a protein carrying the S112A mutation, and 
most combinations which included S112A, (S112A/S393A, S112A/S468A, 
S112A/S482A, S112A/S393A/S468A, S112A/S468A/S482A, 
S112A/T131A/S393A/S468A/S482A) showed a significantly reduced basal level of 
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Table 1:  VP16-USPII showing possible protein kinase C phosphorylation mutations, mutational 
combinations, and locations in VP16-USPII 
Name DBD LBD 
VP16-USPII (T131A) T131A   
VP16-USPII (S112A) S112A   
VP16-USPII (S393A)   S393A 
VP16-USPII (S468A)   S468A 
VP16-USPII (S482A)   S482A 
VP16-USPII (S112A/T131A) S112A/T131A   
VP16-USPII (S393A/S468A)   S393A/S468A 
VP16-USPII (S393A/S482A)   S393A/S482A 
VP16-USPII (S468A/S482A)   S468A/S482A 
VP16-USPII (S112A/S393A) S112A S393A 
VP16-USPII (S112A/S468A) S112A S468A 
VP16-USPII (S112A/S482A) S112A S482A 
VP16-USPII (LBD PKC)   S393A/S468A/S482A 
VP16-USPII (S112A/S393A/S68A) S112A S393A/S468A 
VP16-USPII (S112A/S68A/S482A) S112A S468A/S482A 
VP16-USPII (LBD + T131A PKC) T131A S393A/S468A/S482A 
VP16-USPII (LBD + S112A/T131A 
PKC) S112A/T131A S393A/S468A/S482A 
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Figure 2: Effects of individual mutations and mutational combinations of VP16-USPII compared to basal 
and induced transcriptional activity (1.0, 11.2 respectively), with wild-type USP and EcRB1.  DBD: DNA 
Binding Domain; LBD: Ligand Binding Domain. Red x’s indicate that the construct had a significant effect 
(P<0.05, t-test) on basal and induced levels of transcription, blue x’s indicate no effect. 
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transcriptional activity and a reduced level in the presence of a supermaximal dose of 
murA, demonstrating an effect on hsp27 EcRE mediated transcription (Figure 3).  
However, fold induction was not reduced.  All three isoforms were tested with the S112A 
mutant USP because in previous studies (Beatty et al., 2006), USP have yielded different 
results with each isoform.  The same pattern was observed with all three of the EcR 
isoforms with each DBD USP mutant (Figure 4).  S112A, T131A, and the combination of 
the two were also tested with EcRB1 and basal, 1μM, and 5μM murA (Figure 5).  The 
S112A mutation presented with a reduced basal transcriptional activity and reduced 
ligand-dependent transcription at both 1μM and 5μM murA.  T131A and S112A/T131A 
had a similar transcriptional activity and fold induction with 1μM, and 5μM murA as the 
wildtype.  
Chelerythrine Chloride Treatment 
VP16-USPII (S393A/S468A/S482A) and VP16-USPII 
(S112A/T131A/S393A/S468A/S482A) were treated with CC, a PKC inhibitor.  Sun and 
Song (2006) and treated incubated D. melanogaster salivary glands with 100μM CC, and 
the PKC inhibitor elicited a reduction in 20E responsive genes.  The mammalian cells 
were treated with varying levels of the CC because the chemical can lead to apoptosis, 
and therefore the level had to be determined which was below the level that would 
produce programmed cell death.  The levels of CC tested were the following:  100μM, 
50μM, 10μM, 1μM and 0.1μM.  The 100μM and 50μM doses caused apoptosis and 
therefore no results were obtained via the β-gal assay.  The maximal dose that could be  
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Figure 3:  Basal and induced transcriptional activity via an hsp27 EcRE-regulated luciferase gene using D. 
melanogaster EcRB1 with the USP mutant proteins.  Open bars represent relative luciferase activity with no 
hormone; closed bars represent effects of 1µM murA. (N=4 for each data point) All mutant proteins except 
T131A/S393A/S468A/S482A have a common mutation, S112A. 
 
 25
0
2
4
6
8
10
12
DmEcRA/DmUSPII DmEcRA/DmUSPII
S112A
DmEcRB1/DmUSPII DmEcRB1/DmUSPII
S112A
DmEcRB2/DmUSPII DmEcRB2/DmUSPII
S112A
Fo
ld
 I
nd
uc
tio
n
Vehicle
1uM MurA
 
Figure 4: Basal and murA induced transcriptional activity of USP wild-type and USP S112A DBD 
mutation of D. melanogaster VP16-USPII with EcR A, B1 and B2. Open bars represent relative luciferase 
activity with no hormone; closed bars represent effects of 1µM murA. (N=3 for each data point) 
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Figure 5: USP S112A, USP T131A, USP S112A/T131A with no hormone, 1µM murA, and 5µM murA.  
Open bars represent relative luciferase activity with no hormone; gray bars represent effects of 1µM murA; 
closed bars represent effects of 5µM murA. (N=3 for each data point)
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used was 10μM and the mutant USPII forms:  S393A/S468A/S482A, and 
S112A/T131A/S393A/S468A/S482A were treated with CC.  Doses aw low as 1μM CC 
are effective for inhibiting phosphorylation in CHO cells (Zhang et al., 2001)  The 
amounts of plasmid DNA encoding EcR and USP transfected with the cells treated with 
10μM was 250ng, the standard amount for cell culture.  At this level of transfection, there 
was no detectable effect on either basal or ligand-induced transcriptional activity (Figure 
6a).  Nevertheless, it seemed possible that there was a molar excess of EcR and USP for 
the decreased concentration of CC.  To test this possibility, the cell culture was 
transfected with 25ng of the EcR and USP plasmid vectors.  There was still no visible 
effect on the transcriptional activity of the samples treated with the CC compared to the 
untreated wild-type and mutant samples with the reduced EcR and USP (figure 6b).  
Therefore it can be suggested that CC has no effect on EcR/USP transcriptional activity 
mammalian cell culture at the concentration of 10μM. 
Western Blots 
Western blot analysis is an important tool for observing possible differences between the 
mutant USP proteins that are not visible in cell culture.  All of the mutations and 
combinations of mutations were treated with the VP16 antibody to probe for the USP 
protein (Figure 7a).  Although S112A and combinations of mutations with S112A 
demonstrate decreased transcriptional activity, mutant USP proteins did not have a visible 
shift when compared to USP and the mutant proteins that previously showed no effect on 
transcriptional activity (Figure 6b).  The CC treated USPII, S393A/S468A/S482A, and 
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Figure 6: Effects of transfection quantity on transcriptional activity with and without CC treatment. 
(a.)Transfection with 250 ng of USPII, S393A/S468A/S482A and S112A/T131A/S393A/S468A/S482A 
with EcR isoforms B1 and B2. (b.) transfected with 25ng of EcR and USP.  USPII and 
S112A/T131A/S393A/S468A/S482A with EcR isoforms B1 and B2 treated with CC.  Open bars represent 
no hormone or inhibitor, diagonal hatch marks/gray bars represent no hormone with 10µM CC, closed bars 
represent 1µM muristerone A with no inhibitor, and horizontal hatch marks represent 1µM muristerone A 
with 10µM CC. (N=3 for each point) 
EcRB1 
EcRB2 
EcRB2 
EcRB1 
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(a.)  
(b.)  
Figure 7: Western blots from CHO cell extracts with mouse monoclonal IgG VP16 antibody (a.) various 
mutant USP proteins on a 6% gel.  (b.) wild-type (wt), wildtype with chelerythrine chloride (wt+cc), and a 
mixture of wild-type and wild-type with chelerythrine chloride (mix) on a 8% gel.  Each well’s 
concentration was determined by β-gal activity. 
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S112A/T131A/S393A/S468A/S482A were also subjected to Western blotting.  VP16-
USPII, VP16-USPII and CC and a lane with a mixture of the two samples were treated 
with VP16 antibody and no shift in molecular weight or double banding was seen (Figure 
7b).  If phosphorylation had been absent there would be a downward shift in molecular 
weight, or there would be two bands, one of residual phosphorylated USPII protein and 
also a band of unphosphorylated USPII protein at a reduced molecular weight.  Therefore 
it can be suggested that CC has no effect on mammalian cell culture at the concentration 
of 10μM. 
Next, select mutant proteins were treated with an anti-phosphoserine antibody that 
recognizes phosphorylated serine residues within proteins.  The mutations alter the codon 
from either a serine or threonine into an alanine and therefore, would not be recognized 
by an anti-phosphoserine antibody.  The anti-phosphoserine antibody produces multiple 
bands, compared to the one band the VP16 antibody produces, because it detects all 
proteins containing phosphoserine residues.  The mutant proteins that were tested with 
this antibody include: S112A, T131A, S112A/T131A, 
S112A/T131A/S393A/S468A/S482A (Figure 8).  If there was phosphorylation involved 
then that the S112A/T131A/S393A/S468A/S482A protein would not be recognized by 
the antibody, whereas the wild-type protein would be.  The USP signal might also 
disappear when CC was added.  The antibody is not specific to USP, and EcR can also be 
probed for phosphoserines.  These mutations were chosen because the USP with all five 
mutations eliminates all of the computer generated PKC targets.  There was no difference 
observed in the banding pattern and intensity between VP16-USPII and  
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Figure 8: Western blot from CHO cell extracts with a rabbit polyclonal anti-phosphoserine antibody (LC 
Laboratories). lane 1: VP16-dUSPII (wt), lane 2: VP16-dUSPII with CC (wt + CC), lane 3: 
S112A/T131A/S393A/S468A/S482A, land 4: S112A, lane 5: S112A/T131A, lane 6: T131A. 8% gel 
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S112A/T131A/S393A/S468A/S482A.  This indicates that there was no difference in the 
amount of phosphorylated protein.   
The CC treated cells were also probed with the anti-phosphoserine antibody.  The 
banding produced by the CC treated cells was also at the same intensity as the non-
treated cells, therefore these results are inconclusive.
 
 
CHAPTER IV 
DISCUSSION 
A heterologous cell culture system was used to explore the activity of the 
EcR/USP heterodimer when single and multiple mutations of possible PKC mediated 
phosphorylation sites were introduced into the gene that encodes D. melanogaster USP.  
The mutations involved amino acids in the LBD and DBD of VP16-USPII (Beatty et al., 
2006).  While the LBD mutations, either alone or together, had no effect on the 
transcriptional activity in the cell culture system, one of the DBD mutations, S112A, 
reduced transcriptional activity by about 50%, both alone and in conjunction with any 
combination of the three LBD mutations.  Also, the reduction caused by S112A was 
reversed by the effects of T131A, a second mutation in the DBD.  None of the LBD 
mutations, alone or together, affected transcriptional activity.  The western blots provided 
additional insight by showing that the size of USP mutant proteins in comparison to wild-
type protein was the same and that the amount of phosphorylated serines in the cell 
extracts containing mutant proteins, even when treated the CC, were the same as wild-
type.  The S112A mutation by itself or in combination with LBD mutations caused a 
reduction in transcriptional activity, but it cannot be concluded that it affects the 
phosphorylation of the USP protein in vitro.
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Effects of the DBD Mutations 
In the DBD, S112A occurs in the top of the first zinc finger and T131A occurs 
between the two zinc fingers.  Although neither amino acid is involved in an interaction 
with the DNA itself (Devarakonda et al., 2001), these mutations could possibly affect the
capabilities of USP.  The DBD is highly conserved and other insects and mammalian 
RXR’s may exhibit the same effect from these mutations.  To examine residue 
conservation among insect USPs, sixteen different insect species representing several 
different phylogenetic orders and two RXR’s (Mus musculus and Homo sapiens) were 
compared with the D. melanogaster USP sequence.  If these mutations involve a 
conserved residue in D. melanogaster, then it is conceivable that these mutations perform 
an identical role in other species (figure 9).  The USP DBD is highly conserved - 86% of 
the residues are identical among all insect species and only 14% of the residues show any 
variability in their sequence.  All sixteen insect species and the two mammalian RXR’s 
aligned with D. melanogaster contain the S112A and T131 residue or its equivalent. 
S112A vs. usp3 and usp4 
 Recessive early larval lethal mutations usp3 and usp4 occur in the DBD just as 
S112A and T131A.  The usp4 mutation is the amino acid R130C and is just before T131A 
and usp3 is R160H which occurs in the second zinc finger and are also shared among all 
the USP and RXR DBD sequences.  Ghbeish et al., (2001) tested USP3 and USP4 in 
vitro with EcRB1 and the hsp27EcRE.  These two mutant proteins increased induction 
compared to the wild-type EcRB1/USP heterodimer.  By contrast, the S112A mutation,  
 35
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Z
i
n
c
 
F
i
n
g
e
r
 
1
 
 
 
 
 
 
 
L
i
n
k
e
r
 
 
Z
i
n
c
 
F
i
n
g
e
r
 
2
 
D
r
o
s
o
p
h
i
l
a
 
m
e
l
a
n
o
g
a
s
t
e
r
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
T
Y
A
C
R
E
N
R
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
T
C
G
M
 
 
C
h
i
r
o
n
o
m
u
s
 
t
e
n
t
a
n
s
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
E
R
N
C
V
I
D
K
K
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
N
C
G
M
 
 
A
e
d
e
s
 
a
l
b
o
p
i
c
t
u
s
 
 
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
D
K
N
C
T
I
D
K
R
Q
R
N
R
C
L
Y
C
R
Y
Q
K
C
L
A
C
G
M
 
 
L
u
c
i
l
i
a
 
c
u
p
r
i
n
a
 
 
 
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
T
Y
A
C
R
E
D
R
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
C
G
M
 
 
H
e
l
i
o
t
h
i
s
 
v
i
r
e
s
c
e
n
s
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
T
Y
A
C
R
E
E
R
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
C
G
M
 
 
M
a
d
u
c
a
 
s
e
x
t
a
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
T
Y
A
C
R
E
D
R
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
C
G
M
 
 
B
o
m
b
y
x
 
m
o
r
i
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
T
Y
A
C
R
E
D
K
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
C
G
M
 
 
C
h
o
r
i
s
t
o
n
e
u
r
a
 
f
u
m
i
f
e
r
a
n
a
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
E
R
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
C
G
M
 
 
L
e
p
t
i
n
o
t
a
r
s
a
 
d
e
c
e
m
l
i
n
e
a
t
a
 
 
C
S
I
C
G
D
K
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
E
K
N
C
L
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
V
M
G
M
 
 
T
e
n
e
b
r
i
o
 
m
o
l
i
t
o
r
 
 
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
E
K
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
N
M
G
M
 
 
H
y
p
e
r
a
 
p
o
s
t
i
c
a
 
 
 
 
 
 
 
 
 
 
 
 
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
E
K
S
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
M
G
M
 
 
A
p
i
s
 
m
e
l
l
i
f
e
r
a
 
 
 
 
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
E
K
S
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
M
G
M
 
 
L
e
p
t
o
p
i
l
i
n
a
 
h
e
t
e
r
o
t
o
m
a
 
 
 
 
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
T
C
R
E
E
K
T
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
M
G
M
 
F
o
l
s
o
m
i
a
 
c
a
n
d
i
d
a
 
 
 
 
 
 
 
 
 
 
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
P
S
Y
A
C
R
E
D
K
S
C
T
I
D
K
R
H
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
S
M
G
M
 
 
L
i
t
h
o
b
i
u
s
 
f
o
r
f
i
c
a
t
u
s
 
 
 
 
 
 
 
-
-
-
-
-
-
-
-
-
-
E
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
D
R
N
C
V
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
S
M
G
M
 
 
L
o
c
u
s
t
a
 
m
i
g
r
a
t
o
r
i
a
 
 
 
 
 
 
 
 
 
C
S
I
C
G
D
R
A
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
D
K
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
M
G
M
 
 
P
e
r
i
p
l
a
n
e
t
a
 
a
m
e
r
i
c
a
n
a
 
 
 
 
 
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
S
Y
A
C
R
E
D
K
N
C
I
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
G
M
G
M
 
 
H
o
m
o
 
s
a
p
i
e
n
s
 
R
X
R
a
 
 
 
 
 
 
 
 
 
 
C
A
I
C
G
D
R
S
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
T
Y
T
C
R
D
N
K
D
C
L
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
M
G
M
 
 
M
u
s
 
m
u
s
c
u
l
u
s
 
R
X
R
a
 
 
 
 
 
 
 
 
 
 
C
A
I
C
G
D
R
S
S
G
K
H
Y
G
V
Y
S
C
E
G
C
K
G
F
F
K
R
T
V
R
K
D
L
T
Y
T
C
R
D
N
K
D
C
L
I
D
K
R
Q
R
N
R
C
Q
Y
C
R
Y
Q
K
C
L
A
M
G
M
 
 
 
 
 
 
 
S
1
1
2
 
 
 
T
1
3
1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
u
s
p
4
 
 
 
 
 
u
s
p
5
 
 
u
s
p
3
 
F
i
g
u
r
e
 
9
:
 
A
lig
nm
en
t o
f D
B
D
 d
ep
ic
tin
g 
S1
12
, T
13
1,
 u
sp
3 , 
us
p4
 a
nd
 u
sp
5  m
ut
at
io
ns
, z
in
c 
fin
ge
rs
 a
nd
 li
nk
er
 b
et
w
ee
n 
th
e 
fin
ge
rs
 
 36
which is also conserved, decreased induction by about 50%.  This suggests that mutations 
of conserved amino acids within the same domain could be working through a different 
mechanism, though it remains unknown what effect S112A would have on USP function 
in vivo.  There are a couple of functions the S112A mutation could affect:  DNA binding 
affinity for the receptor to the EcRE and/or USP’s dimerization to EcR. The mutation is 
not affecting the ligand-dependent transcription because the mutation causes a reduction 
in both basal and induced levels. 
Effects of the LBD Mutations 
In the LBD the mutations are:  S393A is in Helix 7, S468A is in Helix 10, and 
S482A is just outside of Helix 11 (Figure 10).  The LBD is less conserved than the DBD 
(49%) and consequently, it might be expected that the serine residues within this domain 
are not as highly conserved among insect species.  Out of the three mutations in this 
domain, S468 is the most conserved with seven of the seventeen total insect species 
represented conserving the serine with all of these species either in the order Diptera 
(flies and mosquitoes) or Lepidoptera (moths and butterflies).  The S393 position is as 
conserved as S468, with six of the seventeen insect species sharing a serine at this 
location, also in Diptera and Lepidoptera.  As for S482, there is only one other species, 
Aedes albopictus, that carries the serine at this position.  This may simply reflect the fact 
that S393 and S468 both lie in relatively conserved alpha-helices whereas S482 is just 
outside of a helix, where the level of conservation is generally lower. 
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Phosphorylation in Chinese Hamster Ovary cells   
The 10μM CC treatment has shown no effect on the transcriptional activity of 
EcR/USP in the CHO cells for either the wild-type or mutated USP forms.  It is left to 
wonder if these mammalian cells are affected by PKC mediated phosphorylation.  With 
just the results from the cell culture assays, it would signify that the USP protein is not  
phosphorylated.  Through western blotting with the anti-phosphoserine antibody, which 
probes for serine phosphorylated sites in proteins, there are bands present in CC treated 
cells that would indicate that there is phosphorylation present but there is no evidence 
that USP is normally phosphorylated.  Therefore, with the treatment of the anti-
phosphoserine antibody being more indicative than the cell culture assays, it can be 
suggested that many proteins in the CHO cells are phosphorylated since the antibody had 
bound to several unidentified serine phosphorylated proteins. 
Possible Phosphorylation Sites of USP 
 Western blots using the USP-specific AB11mAb in proteins extracted from flies 
show two bands in vivo.  A D. melanogaster/Chironomous tentans chimera was blotted 
and the same banding pattern appeared, although this pattern was at 54kDa and 48kDa 
instead of 56kDa and 54kDa (Henrich et al., 2000).  The function of this chimera was to 
act as a LBD mutation since the entire D. melanogaster LBD was replaced by the 
equivalent C. tentans LBD.  These results could suggest one of two things.  First, it could 
suggest that the N-terminal domain and DBD are the common target for phosphorylation 
since this portion is shared by both the wild-type USP and the chimeric USP.  It is still 
possible that some or all of a phosphorylation occurs in the LBD of Chironomus.  
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Through the results obtained in this investigation, the first possibility seems more likely 
because the mutations in the LBD had no effect on transcription in cell culture but the 
DBD mutations did. 
Other Possible Effects of the Mutations 
 The mutations may have other possible effects than that were found in this study.  
These mutations have only been tested with the hsp27EcRE, therefore it is not known 
how they will affect the other direct repeats and palindromic EcREs that have been 
identified to form a complex with USP/EcR by Vogtli et al., (1998).  Sun and Song 
(2006) noted that when salivary glands are treated with CC, expression of 20E responsive 
genes is affected.  In using cell culture, these genes themselves have not been tested, and 
therefore it is unknown what effects these mutations could have on the 20E responsive 
genes.  Also, USP can achieve high affinity binding with other receptors (Yao et al., 
1992).  USP was only tested with EcR in this system.  We are unable to speculate on the 
possible effects that these USP mutations may have on other receptors that bind to USP.  
S112 is in the first zinc finger, and it is feasible that changing this amino acid to an 
alanine could have a substantial effect on the zinc finger, but without further testing, we 
are unable to know what this mutation does. 
Future Experiments 
 The results obtained from this work lead to numerous experiments in the future.  
Some of these mutations will need to be tested in D. melanogaster, in order to investigate 
if the mutations affect the activity of 20E responsive genes similar so the results from 
Sun and Song (2006) with the CC.  Also, the S112A/T131A/S393A/S468A/S482A USP 
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mutant will need to be tested in D. melanogaster to look for possible phosphorylation 
effects.   These mutations will also need to be compared for developmental effects and 
compared to those of usp3 and usp4.  The N-terminal mutations will need to be tested in 
cell culture with a plasmid that contains the full usp sequence rather than the VP16 
activation domain, because the mutations could possibly cause this non-transcribing 
version used in cell culture to produce results.  The two N-terminal mutations will also be 
tested in D. melanogaster, because these mutations may also cause an effect by 
themselves or in combination with the DBD and LBD mutations.  Lastly, these mutations 
should be tested with other direct repeat and palindromic EcREs to examine the response 
with other elements.
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